| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $289.2M | -53.3% |
| Cost of Revenue | $184.8M | -26.7% |
| Gross Profit | $104.5M | -71.5% |
| R&D Expense | $41.4M | +43.3% |
| SG&A Expense | $89.0M | -19.9% |
| Operating Income | -$195.5M | -209.5% |
| Pre-tax Income | -$174.1M | -194.6% |
| Income Tax | $1.2M | -97.3% |
| Net Income | -$167.8M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $97.5M | +22.6% |
| Accounts Receivable | $51.1M | -3.1% |
| Current Assets | $507.8M | -19.1% |
| Total Assets | $1.24B | -10.9% |
| Current Liabilities | $73.0M | -17.1% |
| Total Liabilities | $102.0M | -12.2% |
| Stockholders' Equity | $1.14B | -10.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $27.0M | -89.3% |
| Capital Expenditures | $22.2M | +18.3% |
| Investing Cash Flow | $38.9M | +114.9% |
| Financing Cash Flow | -$47.8M | +38.1% |
| Free Cash Flow | $4.8M | -98.0% |
| -217.0% |